Oxygen (O2) -Sham group: Subjects will receive interventions in a crossover manner at three separate time points over one day as follows:
Time 1: 500 mL of oxygen (flow rate: 1 L/min) Time 2: 500 mL of no air (no oxygen) Time 3: 500 mL of oxygen (flow rate: 1 L/min)
Sham -Oxygen (O2) group: Subjects will receive interventions in a crossover manner at three separate time points over one day as follows:
Time 1: 500 mL of no air (no oxygen) Time 2: 500 mL of oxygen (flow rate: 1 L/min) Time 3: 500 mL of oxygen (flow rate: 1 L/min)
Study summary
This single-center, double-blind, randomized, intra-individual crossover controlled study aims to investigate the efficacy and safety of intestinal oxygen therapy via a deep intestinal catheter as a targeted route for intestinal oxygen delivery in the treatment of ischemic-hypoxic enteropathy, and simultaneously to explore and verify the chronobiological differences. Data have been obtained from the study based on the first version of our pilot study. Considering ethics and cost-effectiveness, a new protocol needs to be designed to achieve the research goals with minimal intervention, minimal cost, and the smallest sample size.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Definite diagnosis of chronic heart failure or obstructive sleep apnea (OSA) with chronic hypoxia;
* Comorbid intestinal dysmotility (abdominal distension, constipation, diarrhea, or abdominal pain);
* Disease duration ≥1 month with poor response to conventional treatment;
* Tolerability of transendoscopic enteral tubing (TET) with successful placement of the tube at the ileocecal junction;
* Age 18-80 years;
* Able to cooperate with bed rest therapy and provide written informed consent.
Exclusion Criteria:
* Oxygenation index \>400 without supplemental oxygen and/or resting oxygen saturation ≥96%;
* Primary organic gastrointestinal diseases, intestinal obstruction, inflammatory bowel disease, or severe hepatic/renal failure;
* Hemodynamically unstable, unable to tolerate sequential intervention (time-sequenced intervention);
* Presence of cough or spinal disorders that prevent maintaining a resting state during bed rest;
* Failure of arterial catheterization or endoscopic tube placement;
* Mental or cognitive impairment that precludes cooperation with assessments.
Primary outcome measure(s)
Changes in arterial blood gas — Perioperative/Periprocedural Arterial blood gas analysis results, including partial pressure of oxygen, oxygen concentration, partial pressure of carbon dioxide, oxygenation index, and concentrations of various ions and electrolytes, were obtained at baseline and at intermittent time points within a 30-minute period
Trial sites (1)
Facility
City
Region
Status
The Second Affiliated Hospital of Nanjing Medical University
Nanjing
Jiangsu
Recruiting
More The Second Hospital of Nanjing Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.